Nucleus Biologics Launches QuickStart Media™: A Suite of Optimized Media Formulations That Provide a Head Start on Your Therapy Optimization - bioinformant.com/nucleus-biolog… Nucleus Biologics

DigniFI Fecal Incontinence Study: First Participant Treated - bioinformant.com/dignifi-fecal-… Cook MyoSite announced that the first participant was treated in its two-stage, randomized, controlled Phase III trial.

Certified Advanced Biotherapies Professional (CABP) Credential: The AABB Certified Advanced Biotherapies Professional (CABP) credentialing program is the first and only certification for biotherapies professionals. aabb.org/education/cert…

Uri Lee, CEO of Xcell Therapeutics, on Being a Pioneer in Serum-free, Chemically Defined Media - bioinformant.com/xcell-therapeu… Xcell Therapeutics

Congratulations to ConvEyXO on being the latest addition to BioInformant's "Global Database of Exosome Companies, 2024". ConvEyXO is a Belgian company who is releasing the full therapeutic potential of engineered #exosomes. bioinformant.com/product/exosom…

Elevai Labs Releases Preliminary Positive Research on the Potential of Exosome Technology for Skin Health - bioinformant.com/elevai-labs-in…

NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process - bioinformant.com/nurexone-biolo… NurExone Biologic (TSXV: NRX) (Germany: J90)

SCG Cell Therapy And A*Star Launch Joint Labs With S$30M To Advance iPSC Technology for Scalable GMP Manufacturing Of Cellular Immunotherapies - bioinformant.com/scg-cell-thera… A*STAR Research

The Booming Market for Exosomes in 2024 - bioinformant.com/exosomes-extra…

Elevate Your Expertise in Spine and Orthopedic #Regenerative Treatments, Join Us on October 19th - rmtinstitute.com/rmtitrainingco… The Spinal Motion Segment with Regenerative Treatment Options - Spine Surgeons and Regenerative Clinicians Working Together! RMT Institute

Congratulations to STEMBIO on being added to the "Global Database of #Exosome Companies, 2024". bioinformant.com/product/exosom… STEMBIO is Europe's largest hybrid cGMP center, where cord blood, cell and tissue banking, and related products are manufactured together. Stembio Cell and Tissue Center

Trailhead Biosystems Puts iPSCs on a New Path - bioinformant.com/trailhead-bios…

Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening & Selection of New Therapeutic Candidates bioinformant.com/ncardia-ready-… New assays based on iPSC accelerate drug discovery by giving drug innovators in neurodegenerative diseases high quality data. Ncardia

Clean Meat Market: Stem Cell Derived “Clean Meat” Attracts Billionaires - bioinformant.com/clean-meat-mar… Aleph Farms Balletic Foods BlueNalu Finless Foods FutureMeat GOOD Meat Shojinmeat Project (en) Meatable Mission Barns Modern Meadow Mosa Meat New Age Meats SuperMeat UPSIDE Foods

AABB Releases New Publication: Getting Started in Processing for Biotherapies - bioinformant.com/aabb-new-publi… AABB

BlueRock Receive FDA clearance of IND for Investigational iPSC-derived Cell Therapy OpCT-001 - bioinformant.com/bluerock-ind-i… BlueRock Therapeutics

Leading iPSC Mass Production Equipment Manufacturers - bioinformant.com/ipsc-mass-prod… Miltenyi Biotec Thermo Fisher STEMCELL Technologies Hamilton Company Esco Lifesciences Europe Lonza BD Biosciences BioLife Solutions TreeFrog Therapeutics